Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Pakistan Institute of Living and Learning (PILL) is a premier non-profit research organization focused on mental health and social innovation in Pakistan. Founded in 1998, the institute specializes in the development, cultural adaptation, and evaluation of psychosocial interventions for conditions such as depression, schizophrenia, and self-harm. PILL operates a robust network of research centers across major Pakistani cities and maintains strong academic ties with leading UK universities, including the University of Manchester. Their work emphasizes high-quality clinical trials and the implementation of evidence-based mental health services within low-resource settings. Beyond research, PILL provides extensive training for healthcare professionals and advocates for policy changes to improve national mental health infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pakistan Institute of Living and Learning.